Literature DB >> 2116937

Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies.

T E Robinson1, E Castañeda, I Q Whishaw.   

Abstract

This paper presents evidence from microdialysis experiments that three different behavioural outcomes of depletion of striatal dopamine (DA) by either 6-hydroxydopamine or methamphetamine (sparing of function, recovery of function, and loss of function) may be related to differences in the ability of residual DA neurons to maintain extracellular concentrations of DA. It is shown that when up to 80% of the mesostriatal DA system is destroyed, the remaining DA terminals maintain normal extracellular dopamine concentrations. Following a lesion in the 80-95% range, most animals maintain a relatively normal extracellular concentration of DA, but the ability to respond to increased demand is reduced in some animals. When over 95% of the normal DA input to the striatum is destroyed, there is a sharp drop in the extracellular concentration of DA and a nearly complete loss in the ability to increase DA release upon demand. Thus, this new method of sampling extracellular DA and its metabolites in freely moving animals provides insights into the behavioural capacities of animals and into the neural mechanisms that underlie recovery of function following brain damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116937     DOI: 10.1037/h0084241

Source DB:  PubMed          Journal:  Can J Psychol        ISSN: 0008-4255


  18 in total

1.  Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.

Authors:  D D Song; S N Haber
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

Review 2.  Homers regulate drug-induced neuroplasticity: implications for addiction.

Authors:  Karen K Szumlinski; Alexis W Ary; Kevin D Lominac
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

3.  Lack of reliability in the disruption of cognitive performance following exposure to protons.

Authors:  Bernard M Rabin; Nicholas A Heroux; Barbara Shukitt-Hale; Kirsty L Carrihill-Knoll; Zachary Beck; Chelsea Baxter
Journal:  Radiat Environ Biophys       Date:  2015-05-03       Impact factor: 1.925

Review 4.  Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.

Authors:  Glenda E Gillies; Simon McArthur
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

5.  A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation.

Authors:  Patricia Vergara-Aragon; Claudia L R Gonzalez; Ian Q Whishaw
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

6.  Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons.

Authors:  Xiqun Chen; Lu Xu; Pheona Radcliffe; Baoyong Sun; A William Tank
Journal:  Mol Pharmacol       Date:  2008-03-18       Impact factor: 4.436

7.  Time-dependent recovery from the effects of 6-hydroxydopamine lesions of the rat nucleus accumbens on cocaine self-administration and the levels of dopamine in microdialysates.

Authors:  Glen M Sizemore; Conchita Co; Timothy R Koves; Thomas J Martin; James E Smith
Journal:  Psychopharmacology (Berl)       Date:  2003-09-23       Impact factor: 4.530

8.  Hypertrophy of dopamine neurons in the primate following ventromedial mesencephalic tegmentum lesion.

Authors:  A M Janson; K Fuxe; M Goldstein; A Y Deutch
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

9.  The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.

Authors:  M J Ferris; D Frederick-Duus; J Fadel; C F Mactutus; R M Booze
Journal:  Neuroscience       Date:  2009-01-20       Impact factor: 3.590

Review 10.  Noradrenergic modulation of arousal.

Authors:  Craig W Berridge
Journal:  Brain Res Rev       Date:  2007-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.